ACTIVE

ABBOTT VASCULAR INTERNATIONAL

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result337,3 k €-55,0 %over 1 year

Revenue54,4 M €-0,9 %over 1 year

Equity21,5 M €+1,6 %over 1 year

Workforce102,7 ETP+9,1 %over 1 year

Identity

Source · BCE/KBO

ABBOTT VASCULAR INTERNATIONAL is a Private limited company incorporated in 2007. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 102,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0886.537.933
Incorporation: 18/01/2007
Legal form: Private limited company
Registered office: Culliganlaan 2B
1831 Machelen (Brab.) · FlandreSee on map
Contributed capital: 18 550,00 €
Latest accounts: 31/12/2025
Average workforce: 102,7 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport 70100Activities of head offices 70100Activities of head offices

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 21 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	54,4 M €	-0.9%	54,9 M €	+9.2%	50,3 M €	+5.4%	47,7 M €	-2.6%	49 M €
EBITDA	540,7 k €	-54.3%	1,2 M €	-24.7%	1,6 M €	-49.3%	3,1 M €	-3.9%	3,2 M €
Operating result	313,3 k €	-66.1%	923,2 k €	-32.5%	1,4 M €	-53.4%	2,9 M €	+0.9%	2,9 M €
Net result	337,3 k €	-55.0%	750,1 k €	-48.2%	1,4 M €	-41.0%	2,5 M €	+17.7%	2,1 M €
Balance sheet
Equity	21,5 M €	+1.6%	21,2 M €	+3.7%	20,4 M €	+7.6%	19 M €	+14.9%	16,5 M €
Total assets	54 M €	-2.9%	55,6 M €	+15.0%	48,3 M €	+9.5%	44,1 M €	+4.9%	42,1 M €
Cash	–		–		–		–		–
Debts	31,8 M €	-5.7%	33,8 M €	+23.9%	27,3 M €	+11.3%	24,5 M €	-1.5%	24,9 M €
Other
Workforce	102,7 ETP	+9.1%	94,1 ETP	-1.6%	95,6 ETP	-0.9%	96,5 ETP	+14.3%	84,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 43 ended

Active mandates

Maya Wakim

Director · since 01 janvier 2026

Active

Bradley Jay Slater

Director · since 28 octobre 2022 · until 28 octobre 2028

Active

Samih Al Mawass

Director · since 01 avril 2021

Active

Ended mandates

Benjamin Oosterbaan

Director · since 30 septembre 2019 · until 28 octobre 2022

Ended

Benjamin Oosterbaan

Director · since 30 septembre 2019

Ended

Benjamin Oosterbaan

Manager · since 30 septembre 2019

Ended

H.A.M. Lueb

Director · since 01 avril 2018

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	06/07/2026	24/12/2025	02/07/2024	12/07/2023	30/06/2022	26/07/2021
General meeting	30/06/2026	30/06/2025	28/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	06/07/2026	Dutch	PDF
Full modelCorrection	31/12/2024	30/06/2025	24/12/2025	Dutch	PDF
Full model	31/12/2024	30/06/2025	15/07/2025	Dutch	PDF
Full model	31/12/2023	28/06/2024	02/07/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	12/07/2023	Dutch	PDF
Full model	31/12/2021	30/06/2022	30/06/2022	Dutch	PDF
Full model	31/12/2020	30/06/2021	26/07/2021	Dutch	PDF
Full model	31/12/2019	21/09/2020	29/09/2020	Dutch	PDF
Full modelCorrection	31/12/2018	03/04/2020	06/11/2020	Dutch	PDF
Full model	31/12/2018	03/04/2020	07/04/2020	Dutch	PDF
Full model	31/12/2017	12/02/2019	14/03/2019	Dutch	PDF
Full model	31/12/2016	28/07/2017	18/08/2017	Dutch	PDF
Full model	31/12/2015	17/05/2016	22/06/2016	Dutch	PDF
Full model	31/12/2014	19/05/2015	22/05/2015	Dutch	PDF
Full model	31/12/2013	20/05/2014	04/06/2014	Dutch	PDF
Full model	31/12/2012	21/05/2013	28/05/2013	Dutch	PDF
Full model	31/12/2011	03/08/2012	27/09/2012	Dutch	PDF
Full model	31/12/2010	18/07/2011	18/10/2011	Dutch	PDF
Full model	30/11/2009	18/06/2010	12/08/2010	Dutch	PDF
Full model	30/11/2008	16/06/2009	27/07/2009	Dutch	PDF
Full model	30/11/2007	29/05/2008	02/07/2008	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 43 ended

Active mandates

Maya Wakim

Director · since 01 janvier 2026

Active

Bradley Jay Slater

Director · since 28 octobre 2022 · until 28 octobre 2028

Active

Samih Al Mawass

Director · since 01 avril 2021

Active

Ended mandates

Benjamin Oosterbaan

Director · since 30 septembre 2019 · until 28 octobre 2022

Ended

Benjamin Oosterbaan

Director · since 30 septembre 2019

Ended

Benjamin Oosterbaan

Manager · since 30 septembre 2019

Ended

H.A.M. Lueb

Director · since 01 avril 2018

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates14/01/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/10/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/02/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/11/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/11/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other11/02/2022
ALGEMENE VERGADERING
PDF
Mandates07/12/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/05/2021
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

01/01/2026
nominationMaya Abdel Ahad Wakim — bestuurder
2025
Annual accounts 2025337,3 k €↓
2024
Annual accounts 2024750,1 k €↓
01/09/2024
nominationFilip Simpelaere — commissaris
2023
Annual accounts 20231,4 M €↓
03/10/2023
nominationGraziella Bua — gemachtigd (HR-lastgeving)
03/10/2023
nominationStéphanie van den Daele — gemachtigd (HR-lastgeving)
30/06/2023
reconductionEY Bedrijfsrevisoren BV — commissaris
2022
Annual accounts 20222,5 M €↑
28/10/2022
nominationBradley Jay Slater — bestuurder
2021
Annual accounts 20212,1 M €↑
2020
Annual accounts 20201,5 M €↑
2019
Annual accounts 20191,2 M €↑
2018
Annual accounts 20181,2 M €↑
2017
Annual accounts 20171,2 M €↑
2016
Annual accounts 2016871,6 k €↓
2015
Annual accounts 20151 M €↓
2014
Annual accounts 20141,1 M €↑
2013
Annual accounts 2013234,3 k €↓
2012
Annual accounts 20121,3 M €↓
2011
Annual accounts 20111,8 M €↑
2010
Annual accounts 20101,1 M €↓
2009
Annual accounts 20091,3 M €↑
2008
Annual accounts 2008879,8 k €↓
2007
Annual accounts 20071,4 M €
18/01/2007
IncorporationPrivate limited company

ABBOTT VASCULAR INTERNATIONAL

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline